Curriculum for Specialty Certificate Examination in Gastroenterology

Countdown to the Examination

Saturday, 17 November 2012

Bacterial overgrowth


The gut contains many resident bacteria with anaerobic bacteria, e.g. Bacteroides, bifidobacteria, being 100-1000 times more abundant than aerobic (facultative anaerobes), e.g. EscherichiaEnterobacterEnterococcus.

This gut microflora has major functions:
-metabolic, e.g. fermentation of non-digestible dietary residues into short chain fatty acids as an energy source in the colon.
-initiate vitamin K production.
-control epithelial cell proliferation
-involved in the development and maintenance of the immune system.
-protect the gut mucosa from colonization by pathogenic bacteria.
The upper part of the small intestine is almost sterile, containing only a few organisms derived fromthe mouth. Gastric acid kills most organisms and intestinal motility keeps the jejunum empty.

The normal terminal ileum contains faecal-type organisms, mainly Escherichia coli and anaerobes and the colon has abundant bacteria
Bacterial overgrowth is normally only found associated with a structural abnormality of the small intestine, although it can occur occasionally in the elderly without such abnormality.
E. coli and/or Bacteroides, both in concentrations greater than 106/mL are found as part of a mixed flora. These bacteria are capable of deconjugating and dehydroxylating bile salts, so that unconjugated and dehydroxylated bile salts can be detected in aspirates by chromatography.

The clinical features are chiefly diarrhoea and steatorrhoea. Steatorrhoea occurs as a result of conjugated bile salt deficiency.
The bacteria are able to metabolize vitamin B12 and interfere with its binding to intrinsic factor, thereby leading to B12 deficiency. Conversely some bacteria produce folic acid giving a high serum folate.
Bacterial overgrowth has only minimal effects on other substances absorbed from the small intestine.
The vitamin B12 deficiency is not so severe as to produce a neurological deficit.

Confirmation of bacterial overgrowth is with the hydrogen breath test; aspiration studies are not routinely performed.
Although bacterial overgrowth may be responsible for the presenting symptoms, it must be remembered that many of the symptoms may be due to the underlying small bowel pathology.
Treatment
If possible, the underlying lesion should be corrected (e.g. a stricture should be resected). With multiple diverticula, grossly dilated bowel, or in Crohn's disease, this may not be possible and rotating courses of antibiotics are necessary, such as metronidazole, a tetracycline, or ciprofloxacin.

5 comments:

  1. In the management of small intestinal bacterial overgrowth (SIBO), which of the following is true?

    A. Antibiotic choice should be based on sensitivity analysis of jejunal aspirates.

    B. Once the diagnosis is made continuous antibiotic therapy should be instituted unless a reversible underlying cause is found.

    C. At least 2 antibiotics should be used in combination.

    D. The efficacy of rifaximin in SIBO is based on highly efficient systemic absorption.

    E. Antibiotic therapy in SIBO remains largely empirical.

    correct answer E,

    Antibiotic therapy in SIBO remains largely empiric and has not been the subject of many high quality randomized, controlled clinical trials. There is no evidence that antibiotic sensitivity testing is of value; some instances of SIBO may resolve with one course of antibiotics but most will require intermittent therapy. Even if more long-term therapy is required, courses of antibiotics should be separated by antibiotic-free holidays to minimize the likelihood of resistance. Rifaximin is minimally absorbed and owes its efficacy in SIBO to its intraluminal effects.

    ReplyDelete
  2. Which of the following has the best specificity for the diagnosis of small intestinal bacterial overgrowth (SIBO)?

    A. Jejunal aspiration and culture

    B. Jejunal aspiration and molecular analysis of the microbiota

    C. Lactulose breath hydrogen test

    D. Small bowel series

    E. Glucose breath hydrogen test

    correct answer A,
    Though subject to criticism on a number of fronts, jejunal aspiration with culture and quantification of the number of colony forming units remains the most validated test for SIBO and while it may pose technical challenges and be subject to false negatives, it is highly specific for SIBO and more so than any of the breath tests. While molecular analysis offers much promise, it has yet to be validated in SIBO. Small bowel series may be useful in detecting a cause of SIBO but will not assist in the diagnosis of SIBO, per se.

    ReplyDelete
  3. Which of the following clinical features are associated with small intestinal bacterial overgrowth (SIBO)?

    A. Folate deficiency

    B. Protein-losing enteropathy

    C. Vitamin K deficiency

    D. Intestinal lymphoma

    E. Enhanced iron absorption

    correct answer B,
    Anemia, in SIBO, is usually macrocytic because of malabsorption of vitamin B12 as a result of the binding and incorporation of this vitamin into the bacteria. Levels of both folate and vitamin K are, however, usually normal or elevated due to bacterial synthesis of these vitamins. Iron deficiency may occur as a consequence of bleeding from ulcers or erosions. In severe SIBO, mucosal injury my result in a protein-losing enteropathy. There is no direct association between SIBO and intestinal lymphoma.

    ReplyDelete
  4. SIBO classically causes a megaloblastic anemia due to vitamin B12 deficiency that is not reversible by use of intrinsic factor. Vitamin B12 deficiency is caused by bacterial consumption of the vitamin within the intestinal lumen before it can be absorbed across the mucosa. Anaerobic organisms mainly are responsible for the vitamin B12 deficiency. Unlike aerobic bacteria, anaerobes can use vitamin B12 in both its free form and as a complex with intrinsic factor. Anaerobic bacteria deprive the host of ingested vitamin B12 and exacerbate its deficiency by using ingested vitamin B12 to produce inactive cobamides that then compete with dietary vitamin B12 for ileal binding sites, thereby decreasing absorption of the vitamin.

    ReplyDelete
  5. I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
    liver already present. I started on antiviral medications which
    reduced the viral load initially. After a couple of years the virus
    became resistant. I started on HEPATITIS B Herbal treatment from
    ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
    treatment totally reversed the virus. I did another blood test after
    the 6 months long treatment and tested negative to the virus. Amazing
    treatment! This treatment is a breakthrough for all HBV carriers.

    ReplyDelete